VENLO, Netherlands, Feb. 28, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- QIAGEN, the world’s leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics, today announced, that the County Hospital in Halmstad, Sweden, confirmed reliable detection of a new strain of the bacterium Chlamydia trachomatis (C. trachomatis) using two of QIAGEN’s artus(r) C. trachomatis PCR Kits*.
